HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2,2- dimethyl- N- (5- methyl- 4- (morpholinomethyl)pyridin- 2- yl)butanamide

structure in first source

Also Known As:

2,2-dimethyl-MMPB

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Aminopyridines: 77
    - 2,2-dimethyl-N-(5-methyl-4-(morpholinomethyl)pyridin-2-yl)butanamide: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Aminopyridines: 77
      - 2,2-dimethyl-N-(5-methyl-4-(morpholinomethyl)pyridin-2-yl)butanamide: 1
  - Oxazines: 9
    - Morpholines: 6
      - 2,2-dimethyl-N-(5-methyl-4-(morpholinomethyl)pyridin-2-yl)butanamide: 1

Experts

1.	Broadrup, Robert L: 1 article (10/2009)
2.	Brogdon, Bernice: 1 article (10/2009)
3.	Cassel, Joel A: 1 article (10/2009)
4.	Chu, Guo-Hua: 1 article (10/2009)
5.	DeHaven, Robert N: 1 article (10/2009)
6.	Dolle, Roland E: 1 article (10/2009)
7.	Goodman, Allan J: 1 article (10/2009)
8.	Koblish, Michael: 1 article (10/2009)
9.	LaBuda, Christopher J: 1 article (10/2009)
10.	Le Bourdonnec, Bertrand: 1 article (10/2009)

Related Diseases

1.	Neuralgia (Stump Neuralgia) 10/15/2009 - "Compound 3, that is, 2,2-dimethyl-N-(5-methyl-4-(morpholinomethyl)pyridin-2-yl)butanamide was identified as a potent and selective CB2 agonist exhibiting in vivo efficacy after oral administration in a rat model of neuropathic pain."

Related Therapies and Procedures

1.	Oral Administration